RGRachel E. Geyer

Rachel E. Geyer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rachel E. Geyer has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bridging the gap in Long COVID care: identifying core competencies for primary care curriculum development and evaluation

    by Rachel E. Geyer, Kristen M. O’LOughlin, Cassie Theobald, Donovan Rivera, Jessica Bender, Anita Chopra, Janna Friedly, Nicole L. Gentile

  • Open Access

    Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study

    by Kris Pui Kwan Ma, Tracy Stober, Michael Gottlieb, Rachel E. Geyer, Kristin Rising, Sharon Saydah, Michelle Santangelo, Kristyn Gatling, Dylan Grau, Ralph C. Wang, et al.

    Objective: To examine participants’ motivations and their experiences throughout a decentralized, longitudinal COVID-19 study in the U.S. Methods: We recruited 355 participants from the Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) between November 2022 – March 2023 to answer five qualitative survey questions anonymously. We used an inductive content analysis approach to analyze the data. Results: We identified five key themes from the analysis, which reflected participants’ a) motivations to join the study, b) study benefits, c) perceptions of survey questions, d) experiences with the research process, and e) preferences for disseminating research findings. Participants were motivated to learn with researchers about COVID-19. They expressed divided opinions about the relevance of INSPIRE research questions. They reported difficulties navigating the virtual research platform and the need for making survey participation less cognitively demanding. They sought more regular feedback on study findings. Conclusions: Our findings offered insights into incorporating decentralized participatory methods in longitudinal research, strengthening reciprocal research communications, making virtual research platforms user-friendly, and employing strategies to reduce participants’ cognitive burden in research. Policy Implications: Longitudinal studies should focus on optimizing these aspects of participant engagement to produce rigorous findings that inform policy and practice on lasting effects of COVID-19 including Long COVID.

  • An evaluation of COVID‐19 vaccine messaging platforms in the emergency department

    by Rene Monzon, Carolina Ornelas‐Dorian, Stephanie A. Eucker, Kristin Rising, Kelli N. O'LAughlin, Alena Pauley, Efrat Kean, Rachel Geyer, Cecilia Lara Chavez, Lindsey Shughart, et al.


  • Open Access

    Developing Digital Therapeutics for Chronic Pain in Primary Care: A Qualitative Human-Centered Design Study of Providers’ Motivations and Challenges

    by Kris Pui Kwan Ma, Kari A Stephens, Rachel E Geyer, Maria G Prado, Brenda L Mollis, Susan M Zbikowski, Deanna Waters, Jo Masterson, Ying Zhang

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. Objective: This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. Methods: Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. Results: Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. Conclusions: Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.


  • Perspectives of COVID‐19 vaccine–hesitant emergency department patients to inform messaging platforms to promote vaccine uptake

    by Alexzandra T. Gentsch, Jonathan Butler, Kelli O'Laughlin, Stephanie A. Eucker, AnnaMarie Chang, Herbie Duber, Rachel E. Geyer, Amanda Guth, Hemal K. Kanzaria, Alena Pauley, et al.

    Objectives: Efforts to promote COVID‐19 vaccine acceptance must consider the critical role of the emergency department (ED) in providing health care to underserved patients. Focusing on patients who lacked primary care, we sought to elicit the perspectives of unvaccinated ED patients regarding COVID‐19 vaccination concerns and potential approaches that might increase their vaccine acceptance.Methods: We conducted this qualitative interview study from August to November 2021 at four urban EDs in San Francisco, California; Seattle, Washington; Durham, North Carolina; and Philadelphia, Pennsylvania. We included ED patients who were ≥18 years old, fluent in English or Spanish, had not received a COVID‐19 vaccine, and did not have primary care physicians or clinics. We excluded patients who were unable to complete an interview, in police custody, under suspicion of active COVID‐19 illness, or presented with a psychiatric chief complaint. We enrolled until we reached thematic saturation in relevant domains. We analyzed interview transcripts with a content analysis approach focused on identifying concerns about COVID‐19 vaccines and ideas regarding the promotion of vaccine acceptance and potential trusted messengers.Results: Of 65 patients enrolled, 28 (43%) identified as female, their median age was 36 years (interquartile range 29–49), and 12 (18%) interviews were conducted in Spanish. Primary concerns about COVID‐19 vaccines included risk of complications, known and unknown side effects, and fear of contracting COVID‐19 from vaccines. Trust played a major role for patients in deciding which sources to use for vaccine information and in engendering vaccine acceptance. Health care providers and family or friends were commonly cited as trusted messengers of information.Conclusions: We characterized concerns about COVID‐19 vaccines, uncovered themes that may promote vaccine acceptance, and identified trusted messengers—primarily health care professionals. These data may inform the development of nuanced COVID‐19 vaccine messaging platforms to address COVID‐19 vaccine hesitancy among underserved ED populations.


  • Open Access

    Primary care challenges and strategies for treating chronic pain: Informing development of digital therapeutics (Preprint)

    by Kris Pui Kwan Ma, Kari A. Stephens, Rachel Geyer, Brenda L. Mollis, Susan M. Zbikowski, Deanna Waters, Jo Masterson, Ying Zhang

    BACKGROUND Digital therapeutics have been increasingly used to improve behavioral healthcare but are underutilized in primary care settings. OBJECTIVE This study explored primary care providers’ challenges and strategies in chronic pain management to identify needs and practice gaps for future development of chronic pain-related digital therapeutics tailored to primary care settings. METHODS Using a human-centered design approach, qualitative semi-structured interviews were conducted with healthcare providers (N = 11) recruited from four primary care clinics in Washington and Colorado between July and October 2021. Providers shared their goals and priorities in chronic pain management, experiences with challenges and strategies used to care for patients, and their perceptions of applying digital therapeutics in clinical practice. Transcripts were analyzed using a thematic analysis approach. RESULTS Our study found four themes related to provider needs: patient-provider alliance, team-based care, tracking and monitoring, and social determinants of health. Providers desired resources to improve chronic pain conversations, pain education and counseling, and goal setting with patients. Providers needed a greater accessibility to multidisciplinary care team consultations and non-pharmacological pain treatments. Healthcare system infrastructure was needed for providers to systematically track and monitor patients’ pain and provide wraparound health and social services for underserved patients. CONCLUSIONS Leveraging digital therapeutics in a feasible, appropriate and acceptable way to aid primary care providers in chronic pain management may require multimodal features that address provider needs at an individual care and clinic/system level.

  • Open Access

    Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study

    by Rachel E Geyer, Jack Henry Kotnik, Victoria Lyon, Elisabeth Brandstetter, Monica Zigman Suchsland, Peter D Han, Chelsey Graham, Misja Ilcisin, Ashley E Kim, Helen Y Chu, et al.

    Background: Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. Objective: This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. Methods: We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. Results: A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. Conclusions: The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.


  • Open Access

    Diagnostic Accuracy of an At-Home, Rapid Self-test for Influenza: Prospective Comparative Accuracy Study (Preprint)

    by Rachel E Geyer, Jack Henry Kotnik, Victoria Lyon, Elisabeth Brandstetter, Monica Zigman Suchsland, Peter D Han, Chelsey Graham, Misja Ilcisin, Ashley E Kim, Helen Y Chu, et al.

    BACKGROUND Rapid diagnostic tests (RDTs) for influenza used by individuals at home could potentially expand access to testing and reduce the impact of influenza on health systems. Improving access to testing could lead to earlier diagnosis following symptom onset, allowing more rapid interventions for those who test positive, including behavioral changes to minimize spread. However, the accuracy of RDTs for influenza has not been determined in self-testing populations. OBJECTIVE This study aims to assess the accuracy of an influenza RDT conducted at home by lay users with acute respiratory illness compared with that of a self-collected sample by the same individual mailed to a laboratory for reference testing. METHODS We conducted a comparative accuracy study of an at-home influenza RDT (Ellume) in a convenience sample of individuals experiencing acute respiratory illness symptoms. Participants were enrolled in February and March 2020 from the Greater Seattle region in Washington, United States. Participants were mailed the influenza RDT and reference sample collection materials, which they completed and returned for quantitative reverse-transcription polymerase chain reaction influenza testing in a central laboratory. We explored the impact of age, influenza type, duration, and severity of symptoms on RDT accuracy and on cycle threshold for influenza virus and ribonuclease P, a marker of human DNA. RESULTS A total of 605 participants completed all study steps and were included in our analysis, of whom 87 (14.4%) tested positive for influenza by quantitative reverse-transcription polymerase chain reaction (70/87, 80% for influenza A and 17/87, 20% for influenza B). The overall sensitivity and specificity of the RDT compared with the reference test were 61% (95% CI 50%-71%) and 95% (95% CI 93%-97%), respectively. Among individuals with symptom onset ≤72 hours, sensitivity was 63% (95% CI 48%-76%) and specificity was 94% (95% CI 91%-97%), whereas, for those with duration >72 hours, sensitivity and specificity were 58% (95% CI 41%-74%) and 96% (95% CI 93%-98%), respectively. Viral load on reference swabs was negatively correlated with symptom onset, and quantities of the endogenous marker gene ribonuclease P did not differ among reference standard positive and negative groups, age groups, or influenza subtypes. The RDT did not have higher sensitivity or specificity among those who reported more severe illnesses. CONCLUSIONS The sensitivity and specificity of the self-test were comparable with those of influenza RDTs used in clinical settings. False-negative self-test results were more common when the test was used after 72 hours of symptom onset but were not related to inadequate swab collection or severity of illness. Therefore, the deployment of home tests may provide a valuable tool to support the management of influenza and other respiratory infections.

  • Open Access

    Gender norms and mass deworming program access in Comé, Benin: A qualitative assessment of gender-associated opportunities and challenges to achieving high mass drug administration coverage

    by Rachel E. Geyer, Moudachirou Ibikounlé, Mira Emmanuel-Fabula, Amy Roll, Euripide Avokpaho, Abiguel Elijan, Léopold Codjo Wèkè, Comlanvi Innocent Togbevi, Félicien Chabi, Parfait Houngbégnon, et al.

    The World Health Organization’s Neglected Tropical Disease Roadmap has accelerated progress towards eliminating select neglected tropical diseases (NTDs). This momentum has catalyzed research to determine the feasibility of interrupting transmission of soil-transmitted helminths (STH) using community-wide mass drug administration (MDA). This study aims to identify potential gender-specific facilitators and barriers to accessing and participating in community-wide STH MDA, with the goal of ensuring programs are equitable and maximize the probability of interrupting STH transmission. This research was conducted prior to the launch of community-wide MDA for STH in Comé, Benin. A total of 10 focus group discussions (FGDs) were conducted separately among 40 men, 38 women, and 15 community drug distributors (CDDs). Salient themes included: both men and women believe that community-wide MDA would reduce the financial burden associated with self-treatment, particularly for low income adults. Community members believe MDA should be packaged alongside water, sanitation, and other health services. Women feel past community-wide programs have been disorganized and are concerned these distributions will be similar. Women also expressed interest in increased engagement in the implementation of future community-based public health programs. Men often did not perceive themselves to be at great risk for STH infection and did not express a high demand for treatment. Finally, the barriers discussed by CDDs generally did not align with gender-specific concerns, but rather represented concerns shared by both genders. A door-to-door distribution strategy for STH MDA is preferred by women in this study, as this platform empowers women to participate as health decision makers for their family. In addition, involving women in planning and implementation of community-wide programs may help to increase treatment coverage and compliance. Soil-transmitted helminths (STH) affect an estimated 1.5 billion people globally. The DeWorm3 Project is investigating if it is possible to interrupt transmission of STH with community-wide deworming of individuals of all ages. We conducted focus group discussions with adult men, women, and community drug distributors (CDDs) in Comé, Benin to identify gender-specific facilitators and barriers to accessing and participating in community-wide mass drug administration (MDA) programs. Our findings suggest that door-to-door community-wide MDA may not only improve MDA treatment coverage by increasing access but may also empower women by facilitating increased decision making on behalf of their regarding who is treated and where. Additionally, women may be an untapped resource for strategically reaching missed populations and women reported seeking increased involvement within the deworming of their families. Men did not perceive themselves to be at risk and thus did not have high demand for deworming. Both genders reported that they struggle to afford deworming drugs outside of MDA and that MDA coverage would be higher if treatment was integrated with water and sanitation services. Finally, CDDs generally identified only barriers and facilitators to MDA that were shared by both genders and may require more training to ensure MDA programs are equitable and effectively engage all at risk populations.